BioCryst Pharmaceuticals Inc (BCRX)
7.49
+0.19
(+2.60%)
USD |
NASDAQ |
Nov 21, 16:00
7.485
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Shareholders Equity (Quarterly): -468.56M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -468.56M |
| June 30, 2024 | -475.61M |
| March 31, 2024 | -476.17M |
| December 31, 2023 | -455.53M |
| September 30, 2023 | -410.99M |
| June 30, 2023 | -388.71M |
| March 31, 2023 | -328.29M |
| December 31, 2022 | -294.60M |
| September 30, 2022 | -242.66M |
| June 30, 2022 | -213.23M |
| March 31, 2022 | -164.22M |
| December 31, 2021 | -106.99M |
| September 30, 2021 | -147.04M |
| June 30, 2021 | -106.08M |
| March 31, 2021 | -74.99M |
| December 31, 2020 | -19.26M |
| September 30, 2020 | 33.64M |
| June 30, 2020 | 76.51M |
| March 31, 2020 | 3.648M |
| December 31, 2019 | 38.25M |
| September 30, 2019 | -41.25M |
| June 30, 2019 | -9.193M |
| March 31, 2019 | 22.51M |
| December 31, 2018 | 49.24M |
| September 30, 2018 | 72.87M |
| Date | Value |
|---|---|
| June 30, 2018 | 46.18M |
| March 31, 2018 | 62.05M |
| December 31, 2017 | 83.77M |
| September 30, 2017 | 100.63M |
| June 30, 2017 | 24.08M |
| March 31, 2017 | 38.53M |
| December 31, 2016 | 1.578M |
| September 30, 2016 | 3.993M |
| June 30, 2016 | 13.39M |
| March 31, 2016 | 27.80M |
| December 31, 2015 | 47.72M |
| September 30, 2015 | 64.04M |
| June 30, 2015 | 76.09M |
| March 31, 2015 | 64.37M |
| December 31, 2014 | 75.64M |
| September 30, 2014 | 83.45M |
| June 30, 2014 | 90.09M |
| March 31, 2014 | -5.723M |
| December 31, 2013 | -1.126M |
| September 30, 2013 | 3.41M |
| June 30, 2013 | -9.047M |
| March 31, 2013 | -2.84M |
| December 31, 2012 | -0.454M |
| September 30, 2012 | 9.784M |
| June 30, 2012 | 15.66M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-476.17M
Minimum
Mar 2024
76.51M
Maximum
Jun 2020
-211.04M
Average
-188.72M
Median
Shareholders Equity (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 2.912M |
| Perspective Therapeutics Inc | 328.47M |
| Protalix BioTherapeutics Inc | 32.44M |
| Electromed Inc | 41.49M |
| Armata Pharmaceuticals Inc | -50.97M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 491.25M |
| Total Liabilities (Quarterly) | 959.82M |
| Debt to Equity Ratio | -1.699 |
| Current Ratio | 2.781 |
| Net Debt Paydown Yield | 0.29% |